Dr. Henry Robert Herrera Jr., MD

Dr. Herrera practices at DHR Health in Edinburg, Texas, part of DHR Health.

Dr. Herrera's NPI, 1386961720, was assigned on April 26, 2010. Dr. Herrera graduated from UT Southwestern Medical Center in 2010. Dr. Herrera holds Texas license P3347.

Dr. Herrera's primary practice is DHR Health, at 5501 South McColl, Edinburg, TX 78539 in Hidalgo County. The practice phone is (956) 362-8677.

Dr. Herrera's primary practice is DHR Health in Edinburg, Texas, part of DHR Health. The medical group on file is Renaissance Gastroenterology. Dmand AI also links Dr. Herrera to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Herrera practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Herrera's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Herrera is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Herrera is licensed in Texas.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroduodenitis, gastrointestinal bleeding and intestinal diverticulosis among the conditions Dr. Herrera treats.

CMS data shows 299 Medicare services from Dr. Herrera across 10 procedure codes in 2024, for 187 Medicare patients. Medicare paid $25,498 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 187 Medicare patients who saw Dr. Herrera in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Herrera's median patient age at 55, with 60% women.

In 2024, Dr. Herrera wrote 310 Medicare Part D claims for 176 patients. 71% of them were for generic drugs. CMS names the drug for 166 of them, across 6 drugs with 11 or more claims each, at $27,946 in total drug cost. In 2023, CMS named 87 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Herrera for performance year 2024, reported as part of a group. Dr. Herrera accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 127 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Herrera, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Herrera. Dr. Herrera's most frequent co-authors are David J. Case, MD and Timothy P. Pfanner, MD.

CMS Open Payments shows 48 general payments to Dr. Herrera from 13 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 88% of the total. AstraZeneca Pharmaceuticals LP paid the most, $15,395.

Dr. Herrera graduated from UT Southwestern Medical Center in 2010.

Dr. Herrera is in network with 24 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.